Physician profile
Ming-Tyh Maa
NPI 1073718722
$22,085.91
in general payments reported to CMS, 2019-2025
45 companies · $3,219 in 2025
The $3,219 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $288 · 2021: $183 · 2022: $3,884 · 2023: $3,867 · 2024: $10K · 2025: $3,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,242 · Food and Beverage: $6,673 · Education: $2,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,241.80 |
| Food and Beverage | $6,672.89 |
| Education | $2,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,075.20 | 2022-2025 | Da Vinci Surgical System |
| Pulmonx Corporation | $3,668.58 | 2022-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Olympus Corporation of The Americas | $2,562.30 | 2023-2025 | Spiration Valve System, Single Use Suction Valve (Sterile), Olympus |
| Inspire Medical Systems, INC. | $1,938.88 | 2024-2025 | Inspire |
| Medical Device Business Services, INC. | $1,646.79 | 2022-2024 | Monarch |
| Ethicon INC. | $985.78 | 2022-2024 | Monarch Platform |
| Astrazeneca Pharmaceuticals LP | $749.93 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.51 | 2019-2025 | Ofev, Jascayd |
| Body Vision Medical INC. | $296.66 | 2022 | |
| Glaxosmithkline, LLC. | $258.91 | 2019-2024 | Nucala |
| Atricure, INC. | $227.64 | 2024-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Merck Sharp & Dohme LLC | $188.92 | 2019-2025 | Winrevair, Recarbrio, Zerbaxa |
| Inari Medical, INC. | $185.45 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Erbe USA INC | $156.13 | 2023-2024 | Cryo2, Erbe Cyo2 |
| Genzyme Corporation | $151.15 | 2020-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming-Tyh Maa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.